These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 31901183)

  • 1. Potentiality of Protein phosphatase Mg
    Yu M; Hu J; He D; Chen Q; Liu S; Zhu X; Li B
    J Clin Lab Anal; 2020 May; 34(5):e23171. PubMed ID: 31901183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPM1D Knockdown Suppresses Cell Proliferation, Promotes Cell Apoptosis, and Activates p38 MAPK/p53 Signaling Pathway in Acute Myeloid Leukemia.
    Li B; Hu J; He D; Chen Q; Liu S; Zhu X; Yu M
    Technol Cancer Res Treat; 2020; 19():1533033820942312. PubMed ID: 32691668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of A-kinase interacting protein 1 as a potential biomarker for risk and prognosis of acute myeloid leukemia.
    Yan Y; Li X; Gao J
    J Clin Lab Anal; 2020 May; 34(5):e23055. PubMed ID: 32356617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of integrin α7 for acute myeloid leukemia risk and its correlation with prognosis in acute myeloid leukemia patients.
    Zeng M; Ding S; Zhang H; Huang Q; Ren Y; Guo P
    J Clin Lab Anal; 2020 Apr; 34(4):e23151. PubMed ID: 31855276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A-kinase interacting protein 1 might serve as a novel biomarker for worse prognosis through the interaction of chemokine (C-X-C motif) ligand 1/chemokine (C-X-C motif) ligand 2 in acute myeloid leukemia.
    Hao X; Gu M; Sun J; Cong L
    J Clin Lab Anal; 2020 Feb; 34(2):e23052. PubMed ID: 31617252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of long non-coding RNA MVIH as a prognostic marker and therapeutic target in acute myeloid leukemia.
    Jiang Z; Yu Q; Luo X
    J Clin Lab Anal; 2020 Apr; 34(4):e23113. PubMed ID: 31724217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IER3 (IEX-1) dysregulation serves as a potential prognostic factor in acute myeloid leukemia patients.
    Ke S; Zhang X; Xiang X; Lu Y; An H
    Int J Lab Hematol; 2022 Apr; 44(2):342-348. PubMed ID: 34729939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non‑coding RNA ANRIL is a potential indicator of disease progression and poor prognosis in acute myeloid leukemia.
    Tan Z; Zhu K; Yin Y; Luo Z
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octamer-binding transcription factor 4 correlates with complex karyotype, FLT3-ITD mutation and poorer risk stratification, and predicts unfavourable prognosis in patients with acute myeloid leukaemia.
    Xiang Y; Zhou X
    Hematology; 2018 Dec; 23(10):721-728. PubMed ID: 29950146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of circular RNA plasmacytoma variant translocation 1 as a biomarker for prognostication of acute myeloid leukemia.
    Chen T; Chen F
    Hematology; 2021 Dec; 26(1):1018-1024. PubMed ID: 34871521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
    Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
    J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPM1D mutations appear in complete remission after exposure to chemotherapy without predicting emerging AML relapse.
    Al Hinai ASA; Grob T; Rijken M; Kavelaars FG; Zeilemaker A; Erpelinck-Verschueren CAJ; Sanders MA; Löwenberg B; Jongen-Lavrencic M; Valk PJM
    Leukemia; 2021 Sep; 35(9):2693-2697. PubMed ID: 33589749
    [No Abstract]   [Full Text] [Related]  

  • 13. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
    Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
    Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA Maternally Expressed Gene 3 Is Downregulated, and Its Insufficiency Correlates With Poor-Risk Stratification, Worse Treatment Response, as Well as Unfavorable Survival Data in Patients With Acute Myeloid Leukemia.
    He C; Wang X; Luo J; Ma Y; Yang Z
    Technol Cancer Res Treat; 2020; 19():1533033820945815. PubMed ID: 32720591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of kinesin family member 2A with increased disease risk, deteriorative clinical characteristics, and shorter survival profiles in acute myeloid leukemia.
    Ding T; Li J; Sun J; Fan X; Shi C; Zhou D; Deng R
    Braz J Med Biol Res; 2020; 54(2):e9173. PubMed ID: 33331418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of the FUT family in acute myeloid leukemia.
    Dai Y; Cheng Z; Pang Y; Jiao Y; Qian T; Quan L; Cui L; Liu Y; Si C; Chen J; Ye X; Chen J; Shi J; Wu D; Zhang X; Fu L
    Cancer Gene Ther; 2020 Feb; 27(1-2):70-80. PubMed ID: 31209266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of long non-coding RNA taurine-upregulated gene 1 with disease conditions and prognosis, as well as its effect on cell activities in acute myeloid leukemia.
    Qin J; Bao H; Li H
    Cancer Biomark; 2018; 23(4):569-577. PubMed ID: 30452403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD45 correlates with adverse risk stratification, decreased treatment response and unfavorable survival profiles in elderly acute myeloid leukemia patients.
    Guo L; Chen L; Wang H
    Cancer Biomark; 2018; 23(3):455-463. PubMed ID: 30347598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIM-1 mRNA expression is a potential prognostic biomarker in acute myeloid leukemia.
    Cheng H; Huang C; Xu X; Hu X; Gong S; Tang G; Song X; Zhang W; Wang J; Chen L; Yang J
    J Transl Med; 2017 Aug; 15(1):179. PubMed ID: 28851457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A three-gene signature might predict prognosis in patients with acute myeloid leukemia.
    Zhu X; Zhao Q; Su X; Ke J; Yi Y; Yi J; Lin J; Qian J; Deng Z
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32436945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.